| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-06 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |